Evidence map›Paper›PMID 37130116›Full record

ArticlePloS one2023

A CT-based transfer learning approach to predict NSCLC recurrence: The added-value of peritumoral region.

Samantha Bove, Annarita Fanizzi, Federico Fadda, Maria Colomba Comes, Annamaria Catino, Angelo Cirillo, Cristian Cristofaro, Michele Montrone, Annalisa Nardone, Pamela Pizzutilo and 3 more

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. [Advances in radiomics for early diagnosis and precision treatment of lung cancer].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Bladder Cancer and Artificial Intelligence: Emerging Applications.The Urologic clinics of North America · 2024
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Samantha BoveI.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Annarita FanizziI.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Federico FaddaI.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.ORCID 0000-0002-2807-4947
Maria Colomba ComesI.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.ORCID 0000-0003-2903-4389
Annamaria CatinoI.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Angelo CirilloI.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Cristian CristofaroI.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Michele MontroneI.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Annalisa NardoneI.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Pamela PizzutiloI.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Antonio TufaroI.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Domenico GalettaI.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Raffaella MassafraI.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-small cell lung cancer (NSCLC) represents 85% of all new lung cancer diagnoses and presents a high recurrence rate after surgery. Thus, an accurate prediction of recurrence risk in NSCLC patients at diagnosis could be essential to designate risk patients to more aggressive medical treatments. In this manuscript, we apply a transfer learning approach to predict recurrence in NSCLC patients, exploiting only data acquired during its screening phase. Particularly, we used a public radiogenomic dataset of NSCLC patients having a primary tumor CT image and clinical information. Starting from the CT slice containing the tumor with maximum area, we considered three different dilatation sizes to identify three Regions of Interest (ROIs): CROP (without dilation), CROP 10 and CROP 20. Then, from each ROI, we extracted radiomic features by means of different pre-trained CNNs. The latter have been combined with clinical information; thus, we trained a Support Vector Machine classifier to predict the NSCLC recurrence. The classification performances of the devised models were finally evaluated on both the hold-out training and hold-out test sets, in which the original sample has been previously divided. The experimental results showed that the model obtained analyzing CROP 20 images, which are the ROIs containing more peritumoral area, achieved the best performances on both the hold-out training set, with an AUC of 0.73, an Accuracy of 0.61, a Sensitivity of 0.63, and a Specificity of 0.60, and on the hold-out test set, with an AUC value of 0.83, an Accuracy value of 0.79, a Sensitivity value of 0.80, and a Specificity value of 0.78. The proposed model represents a promising procedure for early predicting recurrence risk in NSCLC patients.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansMachine LearningTomography, X-Ray Computed

Identifiers

PMID37130116
PMCPMC10153708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.